SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 55.18 |
| Enterprise Value ($M) | -42.84 |
| Book Value ($M) | 94.74 |
| Book Value / Share | 2.11 |
| Price / Book | 0.58 |
| NCAV ($M) | 93.91 |
| NCAV / Share | 2.09 |
| Price / NCAV | 0.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.13 |
| Return on Assets (ROA) | 0.15 |
| Return on Equity (ROE) | 0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 15.78 |
| Current Ratio | 15.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 100.26 |
| Assets | 101.09 |
| Liabilities | 6.35 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -66.63 |
| Net Income | 12.16 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -63.19 |
| Cash from Investing | 85.08 |
| Cash from Financing | -16.03 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Newtyn Management, LLC | 6.10 | ||
| 13G/A | Tang Capital Partners Lp | 0.00 | -100.00 | |
| 13G/A | Gmt Capital Corp | 0.00 | -100.00 | |
| 13G/A | BML Investment Partners, L.P. | 9.90 | 11.00 | |
| 13G/A | Farallon Capital Partners, L.P. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 46,891 | 202,097 | 23.20 | |
| 141,358 | 39,726 | 355.83 | |
| 78,008 | 21,255 | 367.01 | |
| 137,775 | 20,302 | 678.63 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATHA – Athira Pharma, Inc. | ATRA – Atara Biotherapeutics, Inc. |
| AVIR – Atea Pharmaceuticals, Inc. | AVXL – Anavex Life Sciences Corp. |
| BBIO – BridgeBio Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io